Hjem › Medulloblastom › District of Columbia
Kliniske studier for Medulloblastom i District of Columbia
7 studier for Medulloblastom søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- Children's National Hospital, Washington D.C.
RekruttererFase 1/2
Alder 1 til 25 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07346157Digoxin Medulloblastoma Study
- Children's National Medical Center, Washington D.C.
RekruttererFase 2
12 Months – 30 Years · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Children's National Medical Center, Washington D.C.
RekruttererFase 3
Alder 4 til 21 · Alle kjønn · Oppdatert 25. aug. 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's National Medical Center, Washington D.C.
RekruttererFase 2
Alder 3 til 39 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05096481Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's National Hospital, Washington D.C.
Rekrutterer
12 Months – 39 Years · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05057702Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- Children's National Hospital, Washington D.C.
RekruttererFase 1
Alder 4 til 30 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06514898Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
- Children's National Hospital, Washington D.C.
RekruttererFase 1
Alder 1 til 30 · Alle kjønn · Oppdatert 17. jun. 2026 · NCT06193759Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.